Journal
HUMAN GENETICS
Volume 141, Issue 11, Pages 1723-1738Publisher
SPRINGER
DOI: 10.1007/s00439-022-02441-0
Keywords
-
Categories
Funding
- Heinsius Houbolt foundation
- VELUX Stiftung
- Fighting Blindness Ireland
- Health Research Board of Ireland
- Health Research Charities Ireland
Ask authors/readers for more resources
Usher syndrome is a genetically heterogeneous disease with highly variable clinical manifestations. A recent study has found that variants in the ARSG gene are responsible for Usher syndrome type IV, expanding the phenotypic classification of the disease. This study describes the phenotype of three unrelated individuals with Usher syndrome type IV, identifying multiple novel pathogenic variants and confirming the loss of sulfatase activity in the mutant proteins through functional experiments.
Usher syndrome (USH) is an autosomal recessively inherited disease characterized by sensorineural hearing loss (SNHL) and retinitis pigmentosa (RP) with or without vestibular dysfunction. It is highly heterogeneous both clinically and genetically. Recently, variants in the arylsulfatase G (ARSG) gene have been reported to underlie USH type IV. This distinct type of USH is characterized by late-onset RP with predominantly pericentral and macular changes, and late onset SNHL without vestibular dysfunction. In this study, we describe the USH type IV phenotype in three unrelated subjects. We identified three novel pathogenic variants, two novel likely pathogenic variants, and one previously described pathogenic variant in ARSG. Functional experiments indicated a loss of sulfatase activity of the mutant proteins. Our findings confirm that ARSG variants cause the newly defined USH type IV and support the proposed extension of the phenotypic USH classification.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available